Dulaglutide

Therapeutic Group

Blood Glucose Lowering Drugs, Excluding Insulin

Indication Dosage

Dulaglutide is a medication used to help control blood sugar levels in people with type 2 diabetes. It's prescribed to lower the risk of high blood sugar and can be part of a treatment plan along with diet and exercise.

Type 2 Diabetes Mellitus As Monotherapy If Metformin Inappropriate 

By Sc Inj: 

  • Adult: 0.75 Mg Once Weekly, Dose Can Be Increased To 1.5 Mg Once Weekly For Additional Glycemic Control 

Type 2 Diabetes Mellitus In Combination With Insulin Or Other Antidiabetic Drugs (if Existing Treatment Fails To Achieve Adequate Glycaemic Control) 

By Sc Inj: 

  • Adult: 1.5 Mg Once Weekly

Content

  • Inj 1.5mg: Per ml: Dulaglutide 1.5mg Single-dose Pen

Pregnancy

Not Recommended

Stability

  • Glucagon-like Peptide 1 (glp-1) Receptor Agonist

Contra Indications

  • Severe Gastro-intestinal Disease, Personal Or Family History Of Medullary Thyroid Carcinoma Or In Patients With Multiple Endocrine Neoplasia Syndrome Type 2, Prior Serious, Patients With Active Pancreatitis, Hypersensitivity Reaction To Drug.

Precautions

  • Severe Gastro-intestinal Disease, Personal Or Family History Of Medullary Thyroid Carcinoma Or In Patients With Multiple Endocrine Neoplasia Syndrome Type 2, Prior Serious, Patients With Active Pancreatitis, Hypersensitivity Reaction To Drug.

Lactation

  • Not Recommended.

Side Effects

  • Abdominal Distention And Pain
  • Diarrhoea
  • Constipation
  • Atrioventricular Block
  • Decreased Appetite
  • Dyspepsia
  • Fatigue
  • Flatulence
  • Gastro-oesophageal Reflux Disease
  • Nausea
  • Sinus Tachycardia
  • Vomiting.
  • Rare: Acute Pancreatitis (discontinue Treatment)

Available Brands